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ABSTRACT 
Amavata is one of the challenging diseases for the physicians due to its 
Chronicity, incurability, complications and morbidity. Though, Ama and 
Vata are the predominant pathogenic factors but the disease represents 
Tridoshic vitiation. Vata is the prime moreover and motivator in the 
human body, responsible for the initiation of every kind of activity. The 
affliction of Sandhis by Vata Dosha in association with Ama reflects the 
equal rate of the both Dosha and Dushyas in the causation of this disease. 
The aim is to study the effect of Navak guggulu in the management of 
Amavata. 30 patients of Amavata having textual symptomtology from the 
text Madhava Nidana were randomly selected and enrolled in to the 
study. 
Nakaradi guggulu prakarnam mentioned Navak Guggulu is as like nectar 
in the management of Amavata. Shunthi, Maricha, Pippali, Chitraka, 
Haritaki, Bibhitaka, Amalaki, Nagar Motha, Vidanga and Guggulu are the 
ten ingredients of this formulation. In Navaka Guggulu maximum 
ingredients have Rasa- Katu, Virya -Ushna, Vipaka- Katu, Guna-laghu, 
Ruksha. So Vata -Kaphashamaka may be effective to control Amavata.  
The trial drug in this study was very effective in Agnivardhana and 
Amapachana. It was a very good combination of Shoolahara, Shothaghna 
and Amapachaka Dravyas. Navak Guggulu is very effective in reducing 
pain and stiffness. 
As far as relief of symptoms were concerned, no patient got good result 
(no complaints), 10 patients got moderate result (i.e. 2-step down). 14 
patients got mild result (i.e. 1-step down), and 6 patient got no result i.e. 
no change in complaints. 
 
INTRODUCTION 
 Ayurveda, the fountain head of Indian 
medicine present in this country some thousands of 
years ago, long before the other countries could 
dream of systematizing the Concept of the remedies 
for human ailments. 
It’s a treasure of outputs and data obtained 
through invasive research programme. More than a 
medical system, a culture or lifestyle of millions of 
people, it always gives importance to preventive 
aspects than curative. With the march of time, most 
of the dietary habits, social structure, life style, and 
environment have been changing. Occurrence of 
Amavata on large scale is one of the outcomes of 
this modification. 
Amavata is one of the challenging diseases 
for the physicians due to its Chronicity, incurability, 
complications and morbidity. Modern medical 
science has concluded that even after 
administration of their best drugs, the disease has a 
tendency to persist progress and cripples the 
patient therefore they consider it as a disease of 
remission and replaces. 
In the present era, Amavata is the most 
common disease affecting a large aged populace. 
These degenerative changes in bones and muscles 
arise from the age of 40 years to the age of 65 years. 
The prevalence of this disease is such a great that it 
attracts the mind of the almost all the physicians 
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towards itself. That’s why it becomes duty of the 
research scholar to work on the various aspects of 
this disease. 
As a distinct clinical entity Amavata[1] was 
only described in the Madhava Nidana. It is a 
disease of Madhyama Rogamargas as it affects 
Sandhis and Hridaya Marma. The term desires from 
the words as “Ama” and “Vata”. The Ama when 
combines with Vata dosha and occupies in Shleshma 
sthana results painful disease “Amavata” The 
disease is characterized by various features like 
Sandhi shoola in the nature of Toda, swelling, 
inability of joints movements etc. Though, Ama and 
Vata are the predominant pathogenic factors but 
the disease represents Tridoshic vitiation. Vata is 
the prime moreover and motivator in the human 
body, responsible for the initiation of every kind of 
activity. The other two Doshas (Pitta and Kapha) are 
said to be “Lame” without the motivating force of 
Vata. The primary ‘Seat’ (Sthana) of influence of 
Vata in the body is the area located from the 
umbilicus downwards, primarily in the large 
intestine. Here Vata allows for the proper 
elimination of wastes which allows the body to 
function unobstructed of the three Doshas, Vata is 
the most subtle and easily affected. The affliction of 
Sandhis by Vata Dosha in association with Ama 
reflects the equal rate of the both Dosha and 
Dushyas in the causation of this disease. Moreover 
the chief pathogenic factors, being contradictory in 
nature posses difficulty in planning the line of 
treatment. 
No doubt allopathic system of medicine has 
got an important role to play in overcoming agony 
of pain, restricted movement and disability caused 
by the articular diseases. Simultaneously prolonged 
use of allopathic medicines are not only giving rise 
to many side effects, toxic symptoms and adverse 
reactions but also more serious complications like 
organic lesions etc. are caused by them. Hence the 
management of this disease is merely insufficient in 
other systems of medicine and patients are 
continuously looking with a hope towards 
Ayurveda to overcome this challenge. 
As a non-invasive, safe and cost-effective 
form of treatment, Ayurveda therefore proves an 
ideal medical option. Ayurvedic science, an 
advantage in today’s man life, describes 
Swasthaparayanata, which means maintenance of 
health in one hand and treatment of disease on the 
other. 
To see the above fact, we realize that the 
Ayurveda has a good basic principle of medicine to 
treat the disease. Due to wide spectrum of disease, 
much prevalence in the society and lack of effective 
medication, the disease is being chosen for the 
study. Here we try to see the effect of this drug on 
the disease Amavata. 
AIM AND OBJECTIVES 
Aim: To Study the Effect of Navak Guggulu in the 
Management of Amavata. 
Objectives 
1) Authentication of raw material. 
2) Navak Guggulu will be prepared by standard 
method mentioned in the Samhitas & will be used 
after standardization. 
Material & Methods 
Plan of Work  
The proposed study was done in three levels.  
Level 1: Conceptual review of the subject as per 
Ayurvedic texts and allopathic texts.  
Level 2: Generation of data on Authentification and 
Standardization i.e., Authentification and 
Standardization of ingredients of Navak Guggulu. 
Level 3: Clinical trials.  
Literary Review 
The references of Ama from Brithatrayi 
were thoroughly studied. References of Amavata 
from Vedas, Brithatrayi and Laughutrayi were 
studied and compiled. Literature available on Navak 
Guggulu was also collected and studied. The 
previous work done on this topic by various 
scholars were also collected. Detailed pathogenesis 
of Amavata and its management was studied and 
mentioned. 
Clinical study 
Study design: 
This was two months, single blind, and randomized, 
clinical study. 
Place of Study 
All the patients were enrolled in to study from 
Kaya-Chikitsa OPD of Hospital. 
Selection of Patients  
The 30 patients of Amavata having textual 
symptomtology from the text Madhava Nidana were 
randomly selected and enrolled in to the study. 
Patients were selected irrespective of age, 
sex, religion, occupation Prakriti etc. All the patients 
were examined by Trividha, Ashtavidha, and 
Dashavidha pariksha. They were treated with Navak 
guggulu. Follow up was taken after every 15 days. 
The assessment criteria were assessed very 
carefully and noted down before and after the 
treatment. 
Inclusion Criteria 
Textual criteria from the text Madhav nidan was 
taken as reference.  
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1. Swelling accompanied by pain over joints of 
upper & lower limbs & Trika region. 
2. Scorpion bite like pain 
3. Shifting pain 
4. Stiffness of joints, Morning stiffness 
5. Other associated symptoms like Angamarda, 
Aruchi, Alasya, Jwara, Apaka, Swelling over the 
body.  
Exclusion Criteria 
1. Diseases like Vatarakta, Sandhigatavata. 
2. Rheumatic Fever. 
3. Any other major illness, Amavata upadravas like 
Hrudgraha, Bhrama, Chhardi, etc. 
Trial Drug 
Navak Guggulu: Navak Guggulu was prepared as 
per the guidelines mentioned in Sharangdhara 
Samhita. Authentification was done from the Botany 
Department, Pune University. Standardization was 
done from Late Principal B.V. Bhide Foundation, 
Pune. 
Vati Preparation: The Navak Guggulu consists of 
10 (along with Shuddha Guggulu) drugs and was 
prepared according to the principles of Tablet form. 
Route of administration - Oral  
 Dose – 500 mg twice a day  
Time - After lunch and Dinner 
Duration - 2 months 
Anupana: Lukewarm Water (For patient’s 
convenience and Palatability)  
Follow up: After every 15 days. 
Pathyapathya were advised as per disease. 
Written consent was taken from the patient after 
explaining the risk.  
Proforma were prepared and regular observations 
before, during and after treatment were noted. 
Criteria for Assessment 
Clinical assessment was done according to relief of 
Symptoms & self assessment, on the basis of 
gradation & improvement in the classes.  
Joint Score  
Score 3 : If more than 5 joints.  
Score 2 : joints between 3-5.  
Score 1 : at least 2 joints. 
Score 0 : less than 2 joints.  
The no. of clinically active joints was determined on 
the basis of tenderness on pressure or painful 
passive movements.  
Duration of morning stiffness  
Score 3: above 60 min. 
Score 2 : for 30-59 min.  
Score 1 : for 0-29 min.  
Score 0 : no stiffness 
Severity of Pain (by VAS) 
Score 3 : If severe 
Score 2 : If moderate 
Score 1 : If mild 
Score 0 : If nil 
VAS- Visual Analogue Scale 
There is a 10 cm horizontal line for pain 
assessment. Each centimetre indicate digit from 0 to 
10. 0 indicates no pain. 1 to 4 indicates mild pain 
(Mild pain of bearable nature, comes occasionally). 
5 to 9 indicates moderate pain (difficulty in 
movement of joint, appears frequently and requires 
some Upashaya measures for relief). 10 indicate 
severe pain (More difficulty in moving the joints, 
pain is severs disturbing the sleep and requires 
strong analgesics.). 
Tenderness 
Score 3 : If severe 
Score 2 : If moderate 
Score 1 : If mild 
Score 0 : If nil 
Composite Tenderness Score- 0 score indicates no 
tenderness. Subjective experience of pain indicates 
Mild tenderness. Wincing of face on pressure 
indicates Moderate tenderness. Pain, wincing and 
withdrawal indicate severe tenderness. 
Swelling 
Score 3 : Severely present 
Score 2 : Markedly present 
Score 1 : Slightly present 
Score 0 : Absent 
Swelling of joints was measured by measuring their 
circumference.  
Local Temperature of affected joints 
Score 3 : Severe 
Score 2 : Moderate 
Score 1 : Mild 
Score 0 : If Normal 
Local Temperature of affected joints was assessed 
by comparing local temperature of normal part of 
the body. 
Grip Strength 
Grip Strength was measured by recording the 
pressure that patients can exert by squeezing a 
partially inflated bag (at a starting of 20 mm of Hg) 
of a standard sphegmo-manometer.  
Score 3 : If poor (below 38 mm of Hg) 
Score 2 : If moderate (40-140 mm of Hg) 
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Score 1 : If mild (142-280 mm of Hg) 
Score 0 : If normal (above 282 mm of Hg) 
Functional Score 
Score 3 : Unable to do  
Score 2 : With the help of other person or device  
Score 1 : Able to do with difficulty 
Score 0 : Able to do without any difficulty 
Functional Score was assessed by routine personal 
activities/ work of the patient.  
Overall Score 
1 – 8: Mild Grade I 
9 – 16: Moderate Grade II 
17 – 24: Severe Grade III 
Laboratory investigations 
1. Haemogram  
2. R. A. Factor 
3. E. S. R.  
4. Urine Routine 
Observations 
In this study 30 patients were enrolled. 
Observations noted in this group are as follows. 
Age  
Age in yrs No. of cases % 
< 40 10 33.3 
40 - 14 46.7 
50 + 6 20.0 
Total 30 100 
Majority of the patients i.e. 46.7% are reported in 
age group of 40- while in <40 years 33.3 % patients 
& 20% of patients are above 50 years. 
Sex 
Gender No. of cases 
Males 8 
Females 22 
Total 30 
Among the 30 patients studied in the series, 
majority of patients were female i.e. 73.3 % & 26.7 
% were male. 
Occupation  
Occupation No. of cases % 
Business 2 6.7 
Housewife 20 66.7 
Service 4 13.3 
Worker 4 13.3 
Total 30 100 
Majority of patients were housewives 20 i.e. 66.7 %, 
while servicemen & workers were 4 each i.e.13.3 %, 
& businessmen were 6.7 %. 
 
 
Economic condition  
 SES No. of cases % 
Upper middle 4 13.3 
Lower middle 12 40.0 
Poor 14 46.7 
Total 30 100 
40% of patients were of lower economical status, 
13.3% of patients were of upper economical status 
while majorities 14 i.e. 46.7 % were of poor status.  
Diet 
46.7% patients in the study were vegetarians while 
53.3 % patients were accustomed to mixed diet. 
Prakriti 
Prakruti No. of cases % 
KV 14 46.7 
PV 2 6.7 
VK 4 13.3 
VP 10 33.3 
Total 30 100 
In this study majority of the patients were of 
Kapha vata prakriti they are 14 i.e. 46.7 % followed 
by Vata pitta 33.3 % then Vata kapha were 13.3 % 
then Pitta vata were 6.7 %. 
Agni 
Agni No. of cases % 
Manda 18 60.0 
Sama 2 6.7 
Tikshna 4 13.3 
Visham 6 20.0 
Total 30 100 
In the study, majority of patients were i.e. 
60 % were Mandagni they are 18 in no. while 20 % 
were of Vishamagni then 13.3 % were Tikshnagni & 
6.7 % were Samagni. 
Koshtha 
Koshtha No. of cases % 
Krura 16 53.3 
Madhyam 10 33.3 
Mrudu 4 13.3 
Total 30 100 
Most of the patients i.e. 53.33 % were Krura 
Koshtha followed by Madhyama Koshtha were 33.3 
% & 13.3 % were Mrudu Koshtha. 
Hetu 
Hetu No. of cases % 
Mandagni 8 26.7 
Viruddha aahara 20 66.7 
Viruddha chesta 2 6.7 
Total 30 100 
Diet No. of cases % 
Mixed 16 53.3 
Vegetarian 14 46.7 
Total 30 100 
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In the study the most prevalent Hetu was 
Viruddha aahara i.e. 66.7 % followed by Mandagni 
26.7 %, Viruddha cheshta 6.7 %. 
Religion 
Religion No. of cases % 
Hindu 24 80.0 
Muslim 4 13.3 
Others 2 6.7 
Total 30 100 
80 % patients i.e. 24 were Hindus & 13.3 % were 
Muslims. And 6.7% were from other religion. 
Education 
Education No. of cases % 
Graduate 6 20 
HSC 6 20 
School 18 60 
Total 30 100 
In the study most of the patients had studied up to 
10th standard i.e. 60 %, 20 % were graduate, 20 % 
studied up to HSC.  
Vyadhiutpatti Desha 
Vyadhi Desh No. of cases % 
Aanoop 10 33.3 
Sadharan 20 66.7 
Total 30 100 
In the study most of the patients i.e. 66.7 % belongs 
to Sadharan desha, 33.3 % to Aanoop desha. 
Vyadhiutpatti Kala 
Vyadhi Kala No. of cases % 
Adana 14 46.7 
Visarga 16 53.3 
Total 30 100 
In the study the 53.3 % Vyadhi were produced in 
Visarga kala as compared to Aadana i.e. 46.7 %. 
RESULTS 
         The effect of Navak Guggulu was assessed on the basis of criteria designed. The observations were 
record forms at the interval of 15 days upto 60 days. The result was drawn with appropriate statistical 
techniques. 
Joint score 
Joint score N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.80 0.407 4.0 <0.001 HS 19% 
Day-60 30 2.27 0.450    
 
Joint score Mean In % 
Day-0 2.80  
Day-15 2.53  
Day- 30 2.33  
Day-45 2.27  
Day-60 2.27 19% 
                      This table shows that Navak Guggulu has shown statistically highly significant improvement in 
Joint Score. After 60 days, 19% that is marked improvement was seen. 
Morning Stiffness 
Morning stiffness N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.87 0.346 4.524 <0.001 HS 49% 
Day-60 30 1.47 0.819   
 
Morning stiffness Mean In % 
Day-0 2.87  
Day-15 2.27 
Day- 30 1.87  
Day-45 1.67  
Day-60 1.47 49% 
In case of Morning Stiffness, After 60 days, 49% highly significantly improvement was seen. 
Severity of Pain 
Pain N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.60 0.621 4.617 <0.001 HS 54% 
Day-60 30 1.20 0.551   
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Pain Mean In % 
Day-0 2.60  
Day-15 2.10 
Day- 30 1.47  
Day-45 1.27  
Day-60 1.20 54% 
In case of Severity of pain, 54% improvement seen after 60 days this is highly significant. 
Tenderness 
Tenderness N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.00 .830 4.053 <0.001 HS 46.5% 
Day-60 30 1.07 .254    
 
Tenderness Mean In % 
Day-0 2.00  
Day-15 1.53  
Day- 30 1.27  
Day-45 1.13  
Day-60 1.07 46.5% 
In this table, after 60 days, 46.5% were improved. That means drug is having highly significant result.   
 Swelling 
Swelling N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.27 .691 4.235 <0.001 HS 47.13% 
Day-60 30 1.20 .407    
 
Swelling Mean In % 
Day-0 2.27  
Day-15 1.87  
Day- 30 1.40  
Day-45 1.20  
Day-60 1.20 47.13% 
This table shows after 60 days, 47.13%improvement was seen. So the drug is highly significant in Shotha 
symptoms. 
Local Temperature 
Local temp N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.07 .785 3.619 <0.001 HS 39% 
Day-60 30 1.27 .450   
 
Local temp Mean In % 
Day-0 2.07  
Day-15 1.53 
Day- 30 1.33  
Day-45 1.27  
Day-60 1.27 39% 
In this chart after 60 days, 39%improvement was seen. That means the drug is highly significant. 
Grip Strength 
Grip strength N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 2.07 .583 2.889 0.004 Sig 26.08% 
Day-60 30 1.53 .507   
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Grip strength Mean In % 
Day-0 2.07  
Day-15 1.87 
Day- 30 1.67  
Day-45 1.67  
Day-60 1.53 26.08% 
After 60 days, 26.08% improvement was seen in Grip strength.  This is significant. 
Functional Score 
Functional score N Mean Sd. Wilcoxon Signed Ranks Test Z P In %   
Day-0 30 1.80 0.761 3.579 <0.001 HS 52% 
Day-60 30 0.87 0.629   
 
Functional score Mean In % 
Day-0 1.80  
Day-15 1.27  
Day- 30 1.13  
Day-45 .93  
Day-60 .87 52% 
After 60 days, 52% improvement was seen. That means drug is highly significant. 
Total Score 
Total score N Mean Sd. Wilcoxon Signed Ranks Test Z P In % 
Day-0 30 18.47 3.839 4.787 <0.001 HS 41.14% 
Day-60 30 10.87 3.104    
 
Total score Mean In % 
Day-0 18.47  
Day-15 15.00  
Day- 30 12.47  
Day-45 11.40  
Day-60 10.87 41.14% 
This table shows that Navak Guggulu has shown statistically highly significant improvement in Total Score. 
After 60 days, 41.14% improvement was seen.  
Overall score 
Overall score 0 day 60 day 
Mild (1-8) 0 2 
Moderate (9-16) 10 24 
Severe (17-24) 20 4 
Before starting the treatment 0 patients were from mild score, they came under grade I, 10 patients from 
moderate score i.e. Grade II & 20 patients were from severe score i.e. they were in Grade III. After 60 days of 
treatment 2 patients were from mild score, that they were in grade I, 24 patients from moderate score i.e. 
Grade II. And 4 patients were from severe score i.e. they were in Grade III. 
Relief of symptoms 
Relief of symptoms No of patients 
Good Results (No any complaints.) O 
Moderate Results (2 steps down) 10 
Mild Results (1 steps down) 14 
No Results (No change in complaints) 6 
             As far as relief of symptoms were concerned, no patient got good result (no complaints), 10 patients 
got moderate result (i.e. 2-step down). 14 patients got mild result (i.e. 1-step down). And 6 patient got no 
result i.e. no change in complaints. 
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DISCUSSION 
The spectral concept of health of an 
individual fluctuates within a range varying from 
optimum well being to various degrees of 
dysfunction. The transition from good health to 
dysfunction is called disease. One such disease is 
Amavata. It is characteristically a chronic disorder 
chiefly associated with Sandhi Shula, Sandhi Shotha, 
Sandhi Stabdhata, Ushna sparsha. 
It is a Shula Pradhana vyadhi. The intensity 
of the pain is high grade among the other diseases 
according to Acharya Madhava. The disease varies 
from person to person with its clinical pattern. 
 Due to absence of some suitable remedy, it 
is imposing great challenge before the medical 
world. It runs a very long course and not only 
makes the patients to cripple but may also restrict 
them patients to the bed. 
As the name itself indicates Ama and Vata 
are the main pathogenic factors in the disease 
Amavata. The aetiopathogenesis of Amavata based 
on the disturbance of Agni and Vata dominant 
Tridosha. Excessive consumption of Nidana of 
Amavata in pre-existing stage of Mandagni leads to 
formation of Ama and simultaneous vitiation of 
Tridosha, specially the Vata Dosha. The Samprapti 
starts initially from the Annavaha Srotasa and in 
due course spreads to the other Srotasa a mainly 
Rasavaha, Asthivaha and Majjavaha Srotasa. The 
Dusyas involved in this disease are Rasa, Mansa, 
Asthi and Majja. And Malas are Mutra, Purisha. 
Sandhi is the main site of Abhivyakti of 
Lakshana. Ama, under influence of vitiated Vata, 
comes in Sleshamasthana mainly in Sandhis e.g. Janu 
sandhi, Trik sandhi etc and gets lodged there. Sandhi 
shoola, Sandhi shotha, Sandhi Stabdhata, Ushna 
sparsha are the cardinal features of Amavata. As 
stated earlier, the disease runs a chronic course of 
Jadya, Sankocha; Angavaikalya Mansakshaya etc. are 
responsible for crippling of the patients. Other 
constitutional symptoms like Alasya, Apakti, Aruchi, 
Vibandha, etc. are normally found in the patients of 
Amavata. 
Several formulations have been mentioned 
for the management of Amavata in Ayurvedic 
classics. In Bharat Bhaishajya Ratnakar, Nakaradi 
guggulu prakarnam mentioned Navak Guggulu is as 
like nectar in the management of Amavata. All the 
ingredients of it are easily available and cost 
effective. Shunthi, Maricha, Pippali, Chitraka, 
Haritaki, Bibhitaka, Amalaki, Nagar Motha, Vidanga 
and Guggulu are the ten ingredients of this 
formulation.  
In Navaka Guggulu maximum ingredients 
have Rasa- Katu, Virya -Ushna, Vipaka- Katu, Guna-
Laghu, Ruksha. So Vata -Kaphashamaka may be 
effective to control Amavata.  
Combination of Katu-Rasa and Ushna-Virya 
Pradhana drugs - ‘Navaka Guggulu’ is very well 
indicated in Kapha predominant pathologies 
[Cha.Su.21/23]. Due to its Dipana and Pachana 
property, it breaks the Samprapti of Amavata. 
Pharmacodynamic Properties of Navak Guggulu 
Going through the properties of ingredients 
in Navak Guggulu; most of drugs are Tikta 
Rasatmaka, Ushna viryatmak, Laghu and Ruksha, 
Katu vipaka yukta. On the basis of this, we can infer 
Pharmacodynamic properties of combined drug 
(Navak Guggulu) as follows.  
Rasa - Tikta rasa, Vipaka - Katu, Virya - Ushna, Guna 
- Laghu, Ruksha and Karma - Tridoshaghna, Dipana, 
Pachana, Shothaghna, Shulaghna, Vatanulomana, 
Mruduvirechana, Vibandhanashaka. 
Being Laghu guna, Katu rasa, Ushna veerya it 
does best Amapachana; it will act as Kapha-Vata 
shamaka, Shothahara (anti-inflammatory), 
Anulomana, Shoolahara (analgesic), and 
Srotorodhanivarana. By its Kledapachaka and 
Agnidipana properties it decreases Ama, so helpful 
in Sampraptibhanga in Amavata and reduces 
swelling and stiffness in Amavata. In Amavata 
vibandha (constipation) is one of the symptom that 
decreases (reveals) by Anulomana property. 
Being Katu, Tikshna and Ushna property it 
acts as a Krimighna (antihelmethic) by that useful 
for Amapachana which is one of the cause of 
Amavata. After Amapachana; stiffness of joint also 
reduces. 
The objective of the study was to study the 
effect of Navak Guggulu in the management of 
Amavata. For this purpose, 30 patients fulfilling the 
diagnostic criteria of Amavata were selected.  
Navak Guggulu has prepared by Vati 
kalpana. It was given in the dose of 500 mg twice a 
day after lunch and dinner with the Anupana of 
Luke warm water. The duration of treatment was 
two months and follow up was taken after every 
fifteen days. The results were assessed with regards 
to clinical signs and symptoms, functional capacity, 
laboratory investigations, the results were 
statistically analyzed. 
General Description of Patients 
Age- Majority of the patients belongs to age group 
40 to 50 years i.e. 46.7%. This shows that in the 
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present study prevalence of the disease is high in 
the middle age group. 
Sex- As far as the incidence of the disease according 
to gender is concerned, majority of the patients 
were females i.e. 73.3% as compared to males 
26.7%. This data is also supportive to the 
prevalence ratio of the disease (i.e. ~ 2:1).  
Occupation: Majority of the patients in the study 
was housewives i.e. 66.7%. Viruddhahara, heavy 
work, Afternoon nap may be the reason for the 
prevalence of Amavata in housewives and irregular 
food pattern due to work can be the cause in the 
shift duty workers, and servicemen. 
Economical Status: Majority of the patients was 
from poor economical status i.e. 46.7%. but in 
Ayurvedic literature regarding Amavata, there is no 
direct reference that patients from poor economic 
class are found more. 
Diet: It was found that 53.3% patients consumed 
mixed type of diet while 46.7% were pure 
vegetarians. A considerable number of patients 
about 66.7% were found to be consuming Viruddha 
ahara. Hence it can be inferred that Viruddha ahara 
plays a major role in the aetiopathogenesis of 
Amavata. 
Agni: Majority of the patients had Mandagni i.e., 
60% while 20% had Vishamagni. This can denotes 
that Mandagni is prime cause of Amavata. 
Koshtha Majority i.e. 53.3% had Krura koshtha 
while 33.3% had Madhyama and 13.3% had Mridu 
koshtha. Thus majority patients of Krura koshtha 
were found. 
Prakriti: In the series maximum number of patients 
had Kapha-vata prakriti i.e. 46.7% and 33.3% 
patients had Vata- pitta prakriti. But to conclude the 
correlation between Prakriti and incidence of 
Amavata needs extensive study on this particular 
line. But as stated earlier Navaka Guggulu is very 
well indicated in Kapha predominant pathologies so 
it worked in Amavata pathogenesis. 
Religion: It was found that 80 % patients were 
Hindu, 13.3% were Muslim & 6.7% were from 
other. Although no specific inference can be derived 
as these findings only reflect the predominance of 
religion in this particular region. 
Vyadhiutpatti Kala: In the study the 53.3 % Vyadhi 
were produced in Visarga kala as compared to 
Aadana i.e. 46.7 %. I.e. in considerable number of 
patient’s disease were produced in Visarga kala. 
Hence it can be inferred that Vyadhiutpatti Kala 
plays a vital role in the aetiopathogenesis of 
Amavata. 
 
Effect of Therapy 
Effect on pain in joints 
Pain over the joint is one of the most 
characteristics symptoms of Amavata. Acharya 
Madhava expressed the severity of pain by 
describing it as ‘Vrishchika Danshavata’ (scorpion 
bite). ‘Ama’, the chief culprit in Amavata is carried 
to all sites of Shleshma in the body by vitiated Vata. 
This Ama also causes Avarodha in the Srotasas, 
thereby hampering the Gati of Vata. As the 
pathogenesis progresses this combination of Ama 
and Vata get lodged in the joints and cause severe 
pain and swelling. 
Navaka Guggulu showed on an average 54% 
relief in pain which is statistically highly significant 
(P<0.001). This proves the significant effect of 
Navak Guggulu in Pain. 
Probably by means of Ushna guna, Katu, 
Tikta rasa properties, Navak Guggulu reaches up to 
the subtle levels and brings about both 
Amapachana as well as removal of obstruction 
resulting in to Vatanulomana. Thus, pain in 
Amavata might have been relieved. 
Effect on swelling in joints 
Navak Guggulu showed on an average 
47.13% relief in Shotha which is statistically highly 
significant (P<0.001). This proves the significant 
effect of Navak Guggulu on swelling. 
When Ama obstructs the Sukshma srotasas 
of body, it causes accumulation of Malabhavas i.e. 
Kleda which leads to symptom Sandhi shotha. Due 
to Tikta, Katu rasa, Ushna veerya of Navak Guggulu, 
it may result in to Amapachana and Kleda shoshana, 
and due to Anulomana and Vibandhahara 
properties, removal of obstruction by Ama and 
accumulated Malabhavas may be affected. 
Effect on stiffness 
Overall a statistically highly significant 
(P<0.001) relief of 49% was seen in morning 
stiffness. Thus the efficacy of Navak Guggulu in 
morning stiffness is evident. 
Vitiated Vata propels Ama to Sandhis 
replacing Shleshaka kapha. Hence, normal function 
of Shleshaka kapha is hampered, leading to morning 
stiffness. As Stambha is Sheeta gunatmaka, Ushna 
virya and Katu Tikta rasa of Navak Guggulu may 
have done Vata shamana and Amapachana. And 
thus Navak Guggulu may have relieved morning 
stiffness. 
Effect on tenderness 
When assessed for tenderness 46.5% 
average relief was observed in all patients, which 
was found statistically highly significant (P<0.001). 
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This proves the significant effect of Navak guggulu 
on tenderness. 
Tenderness is mainly due to inflammation 
of joint capsule. Navak guggulu might have 
subsided inflammation due to Laghu guna, Katu 
rasa, Ushna veerya and thus tenderness might have 
reduced. 
Effect on functional capacity 
The effect of therapy on the functional 
capacity was assessed. An average improvement of 
52% was observed. That means drug is highly 
significant (P<0.001).This proves the significant 
effect of Navak Guggulu on functional capacity. 
This improvement in the functional capacity 
might have been due to enhancement of 
nourishment of all the Dhatus by Rasa dhatu; Navak 
Guggulu removes the obstruction in the Srotasas.  
Effect on other associated symptoms 
When the patients were assessed for the 
other associated symptoms, it was observed that 
patients showed relief from Agnidaurbalya, Aruchi, 
Alasya, Angamarda, Anaha, Trishna, Jvara, Apaka, 
Vidvibaddhata, Utsahahani, Nidraviparyaya, 
Bahumutrata, Vidvibaddhata, Angagaurava, 
Anganamshoonata. 
Agnimandya, Ama production, Dhatu kshaya, 
vitiation of Vata due to Ama, are the major events 
taking place in the pathogenesis of Amavata. Thus 
eliciting the above symptoms. 
Navak Guggulu might have relieved the 
obstruction in Rasavaha and Svedavaha srotasas by 
its, Tikshna guna, Katu rasa, Ushna veerya and Katu 
vipaka there by relieving Angamarda and Jvara.  
Navak Guggulu, being Agnivardhaka might 
have improved digestion thus overcoming 
Agnidaurbalya and Apaka. The Vata dosha 
obstructed by Ama in Koshtha gets vitiated causing 
Anaha, Aruchi. Navak Guggulu by Amapachana 
might have relieved the obstruction of Vata by Ama, 
regularizing the normal motion of Apana vayu. Thus 
Anaha, Aruchi might have relieved. 
Vidvibaddhata in Amavata is due to 
obstruction of normal motion of Apana vayu and 
improper Sara-kitta vidhajana. Navak Guggulu 
might have improvised Sara-kitta vibhajana and 
normalized the motion of Apana vayu there by 
might have relieved Vidvibaddhata.  
Dhatvagnimandya in Amavata leads to 
excess production of Kleda and hence leads to 
symptom Bahumutrata. Navak Guggulu might have 
improved Dhatvagnis and minimized Kleda 
formation. Thus Bahumutrata might have relieved. 
Navak Guggulu might have lead to 
production of Samyak rasa dhatu by Agnivardhana 
and Pachana. And hence might have relieved Alasya 
and Utsahahani. 
Navak Guggulu is very good at pain 
relieving. By relieving pain it may have normalized 
the sleep pattern. 
Effect on Lab. Investigations 
Out of 30 patients ESR count has been 
reduced to 33% (i.e.10 out of 30 pts), whereas 26% 
pts shown markedly reduction (i.e.8 out of 30 pts). 
& 40% pts has shown minimum reduction in 
present study. ESR is an acute phase reactant. There 
by is raised in acute conditions. Navak Guggulu 
might have subsides the inflammation of joints 
there by resulting in ESR reduction. 
 Whereas RA factor is being positive 
throughout the study i.e. before treatment and after 
treatment. No specific changes have been seen in 
Haemogram and urine routine before and after the 
treatment.  
CONCLUSIONS 
This therapy provided highly significant 
relief in Pain (54%), Functional activity (52%). 
Stiffness (49%), Swelling of joints (47.13%), 
Tenderness (46.5%), Local temperature (39%) 
Joint score (19%), and significant improvement in 
grip strength (26.08%), i.e., overall total 
improvement is 41.14%.  
In the general associated symptoms patients 
showed relief in Angamarda, Trishna, Jvara, Apaka, 
Annanabhilasha, Bahumutrata, Kukshishoola, 
Nidraviparyaya, Vidvibaddhata and Anaha. 
Hence, we can conclude on the present 
study that, the trial drug in this study was very 
effective in Agnivardhana and Amapachana. It was a 
very good combination of Shoolahara, Shothaghna 
and Amapachaka Dravyas.  
Navak Guggulu is very effective in reducing 
pain and stiffness. It is also effective in reducing 
swelling. No untoward effect was seen in the 
patients during the treatment. As the study was 
included over a small period, a similar study 
performed over a longer period would have 
produced much sharper and more accurate results. 
On the basis of observations of the studies, 
administration of Navak Guggulu may be 
recommended for the management of Amavata. 
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